Tenaya Therapeutics Inc’s filing revealed that its Chief Scientific Officer Hoey Timothy unloaded Company’s shares for reported $23101.0 on Mar 05 ’24. In the deal valued at $7.00 per share,3,300 shares were sold. As a result of this transaction, Hoey Timothy now holds 245,346 shares worth roughly $1.11 million.
Then, Hoey Timothy sold 6,569 shares, generating $35,046 in total proceeds. Upon selling the shares at $5.34, the Chief Scientific Officer now owns 236,146 shares.
Before that, Tingley Whittemore sold 6,500 shares. Tenaya Therapeutics Inc shares valued at $38,090 were divested by the Chief Medical Officer at a price of $5.86 per share. As a result of the transaction, Tingley Whittemore now holds 73,534 shares, worth roughly $0.33 million.
Leerink Partners initiated its Tenaya Therapeutics Inc [TNYA] rating to an Outperform in a research note published on November 30, 2023; the price target was $7. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating.
Price Performance Review of TNYA
On Tuesday, Tenaya Therapeutics Inc [NASDAQ:TNYA] saw its stock fall -2.16% to $4.53. Over the last five days, the stock has lost -1.31%. Tenaya Therapeutics Inc shares have risen nearly 39.81% since the year began. Nevertheless, the stocks have risen 70.30% over the past one year. While a 52-week high of $8.09 was reached on 03/05/24, a 52-week low of $1.66 was recorded on 01/17/24. SMA at 50 days reached $5.24, while 200 days put it at $3.79. A total of 0.3 million shares were traded, compared to the trading of 0.36 million shares in the previous session.
Levels Of Support And Resistance For TNYA Stock
The 24-hour chart illustrates a support level at 4.43, which if violated will result in even more drops to 4.32. On the upside, there is a resistance level at 4.69. A further resistance level may holdings at 4.84. The Relative Strength Index (RSI) on the 14-day chart is 41.70, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.44%. Stochastics %K at 26.71% indicates the stock is a holding.
How much short interest is there in Tenaya Therapeutics Inc?
A steep rise in short interest was recorded in Tenaya Therapeutics Inc stocks on Mar 28, 2024, growing by 0.25 million shares to a total of 3.09 million shares. Yahoo Finance data shows the prior-month short interest on Feb 29, 2024 was 2.84 million shares. There was a rise of 8.09%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 5.43% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.69.
